Coca-Cola is about to report earnings. Here’s what to expect

Coca-Cola is about to report earnings. Here’s what to expect


Bottles of Coca Cola displayed at a grocery store on April 24, 2023 in San Rafael, California.

Justin Sullivan | Getty Images

Coca-Cola is expected to report its second-quarter earnings before the bell Wednesday.

Here’s what Wall Street analysts surveyed by Refinitiv are expecting the company to report:

  • Earnings per share: 72 cents
  • Revenue: $11.75 billion

Like many other food and beverage companies, Coke has been raising prices on products from its namesake soda to Powerade. So far, consumers have been willing to pay more for their favorite drinks, but investors will be watching whether another round of price hikes in the first quarter hurt demand.

After Coke’s rival PepsiCo raised its full-year outlook earlier this month for the second consecutive quarter, investors now expect the Atlanta-based beverage giant to follow suit. Coke is projecting organic revenue growth of 7% to 8% and comparable earnings per share growth of 4% to 5% for 2023.

Coke’s stock has fallen 2% this year, trailing Pepsi shares’ 6% growth in the same period. But Coke’s $270 billion market value still narrowly leads Pepsi’s $263 billion market cap.



Source

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Business

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks

Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Big Food is slimming down. As both consumers and regulators push back against ultra-processed foods, the companies that make them have been splitting […]

Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More